Cargando…

Prevention strategies for Alzheimer’s disease

Symptomatic treatment during the dementia stage of Alzheimer’s disease(AD) cannot delay or halt the progression of this disease. Therefore, prevention in the preclinical stage is likely the most effective way to decrease the incidence of this age-associated neurodegenerative condition, and its assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gauthier, Serge, Wu, Liyong, Rosa-Neto, Pedro, Jia, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514088/ https://www.ncbi.nlm.nih.gov/pubmed/23210473 http://dx.doi.org/10.1186/2047-9158-1-13

Ejemplares similares

In vivo tau staging in Alzheimer’s disease
por: Therriault, Joseph, et al.
Publicado: (2022)

Applications of Alzheimer’s disease staging to clinical trials
por: Therriault, Joseph, et al.
Publicado: (2023)

Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
por: Zimmer, Eduardo Rigon, et al.
Publicado: (2014)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
por: Gauthier, Serge, et al.
Publicado: (2018)

Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
por: Ba, Maowen, et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Rowley, Jared, et al.
Publicado: (2013)

Imaging Alzheimer's disease pathophysiology with PET
por: Schilling, Lucas Porcello, et al.
Publicado: (2016)

Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
por: Wu, Liyong, et al.
Publicado: (2012)

Correction: White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Rowley, Jared, et al.
Publicado: (2013)

CCCDTD5: research diagnostic criteria for Alzheimer's Disease
por: Gauthier, Serge, et al.
Publicado: (2020)

Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum
por: Ng, Kok Pin, et al.
Publicado: (2022)

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
por: Li, Jieying, et al.
Publicado: (2018)

Cholinergic Depletion in Alzheimer's Disease Shown by [(18)F]FEOBV Autoradiography
por: Parent, Maxime J., et al.
Publicado: (2013)

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Involvement of specific striatal subregion contributes to executive deficits in Alzheimer disease
por: Liu, Li, et al.
Publicado: (2023)

Update on the Pharmacological Treatment of Alzheimer’s Disease
por: Massoud, Fadi, et al.
Publicado: (2010)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
por: Mantile, Francesca, et al.
Publicado: (2020)

In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals
por: Zimmer, Eduardo Rigon, et al.
Publicado: (2014)

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2018)

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
por: Gauthier, S., et al.
Publicado: (2018)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer’s Disease
por: Boccardi, Virginia, et al.
Publicado: (2023)

Perspectives on the Tertiary Prevention Strategy for Alzheimer’s Disease
por: Bua, Xian-Le, et al.
Publicado: (2016)

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity
por: Iturria-Medina, Yasser, et al.
Publicado: (2022)

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem
por: Benedet, Andréa L., et al.
Publicado: (2018)

Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer’s Disease
por: Philippens, Ingrid H. C. H. M., et al.
Publicado: (2021)

Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease
por: Tedeschi Dauar, Marina, et al.
Publicado: (2023)

Physical exercise in the prevention and treatment of Alzheimer's disease
por: De la Rosa, Adrian, et al.
Publicado: (2020)

Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
por: Rive, Benoît, et al.
Publicado: (2013)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
por: Tissot, Cécile, et al.
Publicado: (2021)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Alzheimer’s Disease: Treatment Strategies and Their Limitations
por: Passeri, Elodie, et al.
Publicado: (2022)

Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities
por: Parent, Maxime J., et al.
Publicado: (2017)

Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
por: Quan, Meina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c69cfokdcuohulmrmuscj702mb